New antibody aims to stall advanced cancers
NCT ID NCT07292168
First seen Jan 05, 2026 · Last updated May 19, 2026 · Updated 22 times
Summary
This study tests a new drug called OM-RCA-01 in people with several types of cancer that have spread and have a specific marker (FGFR1). The drug is an antibody given by IV every two weeks. The goal is to find a safe dose and see if it can slow tumor growth. About 58 adults with kidney, lung, prostate, breast, or head & neck cancer will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD & NECK CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
A.I. Kryzhanovsky Krasnoyarsk Regional Cancer Center
RECRUITINGKrasnoyarsk, Russia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hadassah Medical
RECRUITINGMoscow, Russia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
I.P. Pavlov First Saint Petersburg State Medical University
RECRUITINGSaint Petersburg, Russia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Republican Clinical Oncology Dispensary
RECRUITINGUfa, Russia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Republican Dispensary of Tatarstan
ACTIVE_NOT_RECRUITINGKazan', Russia
Conditions
Explore the condition pages connected to this study.